Back to company

ELDON BIOLOGICALS A/S: Financial statements 2017

CVR: 26747007

ELDON BIOLOGICALS A/S (CVR 26747007) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 7,982,628 and a net result of DKK 2,615,616 compared with DKK 1,219,431 the year before. That is an increase of 31.4% compared with the year before. Equity amounted to DKK 3,887,239. The solvency ratio was 41.1%. The company had 7 employees in the financial year.

Gross Profit
7,982,628 kr.
Profit/Loss
2,615,616 kr.
Equity
3,887,239 kr.
Total Assets
9,465,714 kr.
Employees
7

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-8 mio.2.6 mio.3.9 mio.7
2016-6.1 mio.1.2 mio.1.3 mio.-
2015-6.1 mio.1.5 mio.319 t.-
2014-4.9 mio.1.1 mio.-1.2 mio.-
2013-4.1 mio.949 t.-2.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ELDON BIOLOGICALS A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

About ELDON BIOLOGICALS A/S

ELDON BIOLOGICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2002. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Kasper Juul Hedegaard. The company is owned by MEDI-TRADE ApS and HOLDINGSELSKABET MLH ApS. The company has 9 employees. In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. Equity amounted to DKK 42,055,949.